CeraVe delivered the clearest headline of the week by launching its new Super Boost Serum on September 2, giving the brand a concrete product story that outpaced everything else in the skincare space. Cetaphil answered with its own visibility push, riding an active Ulta promotion alongside fresh product activity from parent company Galderma across the U.S. market.
La Roche-Posay kept its retail presence strong through a live special-offers page, while Eucerin scored a genuine news catalyst when Beiersdorf announced its DERMOPURE CLINICAL PROBIOM8 launch on September 1, built around new microbiome technology. Neutrogena stayed prominent through ongoing U.S. sunscreen tracking and continued visibility on skincare-discovery platforms. The Ordinary found its relevance in consumer conversation, with U.S. shoppers actively discussing where to buy its products and how to compare it against rivals. Paula's Choice held its place in current skincare brand rankings and retail assortments, while Aveeno and Olay both leaned on personal-care brand comparison data to stay part of the mainstream conversation. Kiehl's closed the list through prestige-focused retail promotions, including Ulta's ongoing beauty event.
The overall picture shows a skincare market where genuine product launches from CeraVe and Eucerin are generating the strongest immediate attention, while retail promotions and consumer brand-ranking data keep the rest of the field — from mass names like Neutrogena to prestige players like Kiehl's — firmly in the mix.
| # | Name | Score | 24h | |
|---|---|---|---|---|
| 1 | S | Sephora | 97.6 | +0% |
| 2 | C | CeraVe | 95.1 | +0% |
| 3 | C | Cetaphil | 90.4 | +0% |
| 4 | L | La Roche-Posay | 86.8 | +0% |
| 5 | E | Eucerin | 83.7 | +0% |
| 6 | N | Neutrogena | 80.5 | +0% |
| 7 | T | The Ordinary | 77.3 | +0% |
| 8 | P | Paula's Choice | 73.9 | +0% |
| 9 | A | Aveeno | 70.6 | +0% |
| 10 | O | Olay | 66.8 | +0% |